Connect Sign In
2008426
SLCO1B1, 1 Variant
SLCO1B1
Ordering Recommendation
Identify individuals at increased risk for statin-related muscle toxicity.
New York DOH Approval Status
This test is New York state approved.
Submit With Order
Specimen Required
Patient Preparation
Collect
Lavender (EDTA) or pink (K2EDTA), or yellow (ACD Solution A or B).
Specimen Preparation
Transport 3 mL whole blood. (Min: 1 mL)
Storage/Transport Temperature
Refrigerated.
Unacceptable Conditions
Plasma or serum. Heparinized specimens. Frozen specimens in glass collection tubes.
Remarks
Stability
Ambient: 72 hours; Refrigerated: 1 week; Frozen: 1 month
Methodology
Polymerase Chain Reaction (PCR)/Fluorescence Monitoring
Performed
Mon, Thu
Reported
5-10 days
Reference Interval
By report
Interpretive Data
Refer to report.
Compliance Category
Note
Hotline History
Hotline History
Date of Change
Test Name Change
Methodology
Performance/Reported Schedule
Specimen Requirements
Reference Interval
Interpretive Data
Note
CPT Code
Component Change
Other Interface Change
New Test
Inactive
CPT Codes
81328
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 2008427 | SLCO1B1, 1 Variant, Specimen | 66746-9 |
| 2008428 | SLCO1B1, 1 Variant,*5 Genotype | 93412-5 |
| 3016893 | EER SLCO1B1 | 11526-1 |
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
- Simvastatin myotoxicity assay
- Statin-induced myopathy assay
SLCO1B1, 1 Variant
